24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Oxford PharmaGenesis is proud to have been a finalist for the prestigious 2023 Communiqué Leadership Award for Action on Workforce Diversity and Inclusion. The awards ceremony took place on Thursday 6 July at the Dorchester Hotel, London, UK.
We have scored a hat-trick, with media brand Medical Marketing and Media (MM+M) listing Oxford PharmaGenesis in its Agency 100 report for a third consecutive year.
Plain language summaries (PLS) present research findings in accessible language and formats and are valuable to many different readers. Journals often use external platforms such as Figshare to host their PLS – but are these locations apparent and visible to readers? We wanted to find out if PLS on Figshare are being shared on social media blogs…
Oxford PharmaGenesis is celebrating another brilliant Learning at Work Week (15–19 May) that has provided colleagues with a packed programme of professional and personal development opportunities.
With a strong biotech and pharmaceutical sector, Melbourne, Australia was the ideal city in which to establish an Oxford PharmaGenesis base for Asia Pacific (APAC). Since 2018, the Melbourne office has seen brilliant growth and success with APAC clients. This year, we celebrate its fifth anniversary and the journey so far. Our Melbourne office opened…
Oxford PharmaGenesis colleagues delivered a workshop on integrated evidence generation planning (IEGP) to Medical Affairs professionals at this year’s MAPS EMEA conference (Lisbon) in May. With a holistic and systematic approach, IEGP addresses many common challenges found in evidence generation planning.
